(Press-News.org) Inequalities in childhood vaccination are widening in England, with uptake rates of five key vaccines consistently lower in young children living in areas of higher deprivation from 2019 to 2023, finds a study published by The BMJ today.
The researchers say vaccine uptake was below the World Health Organization’s recommended 95% target for all vaccinations studied and call for urgent action to strengthen systems for childhood vaccination.
Protecting children from vaccine preventable diseases is a fundamental public health priority. The vaccination schedule in England protects children against 15 diseases including measles, diphtheria, whooping cough, polio, pneumonia and meningitis.
Records show that uptake rates of childhood vaccinations in England have been steadily declining over the past decade but few studies have looked at trends in inequalities.
To address this, researchers set out to assess the effect of socioeconomic deprivation on the uptake of five key vaccinations included in the childhood immunisation schedule in England from 2019 to 2013.
Their findings are based on general practice data for five key vaccines given to children aged up to 5 years in England between April 2019 and March 2023.
The vaccines were first and second doses of the measles, mumps, and rubella vaccine (MMR1 and MMR2), rotavirus vaccine, pneumococcal conjugate vaccine (PCV) booster, and six-in-one (DTaP/IPV/Hib/HepB) vaccine covering diphtheria, tetanus, pertussis (whooping cough), polio, Haemophilus influenzae type b, and hepatitis B).
For each general practice, changes in quarterly vaccine uptake were measured and compared by area deprivation level. Changes in inequality in vaccine uptake over time were also assessed using the slope index of inequality (SII).
The results show that for all vaccinations, the absolute difference in uptake between the least and most deprived groups increased over the study period.
For example, for the six-in-one vaccine, the absolute difference in vaccination uptake between the least and most deprived groups in the starting quarter was 3.3% and increased to 7.4% (4.1 percentage points) by the final quarter of data collection.
The absolute difference for rotavirus vaccination increased from 6.3% to 9.1% (2.8 percentage points), for PCV booster vaccination from 5.6% to 8.6% (3 percentage points), for MMR1 at age 2 years from 5.8% to 8.3% (2.5 percentage points), and for MMR2 at age 5 years from 5.3% to 11.5% (6.2 percentage points).
The most pronounced inequality was seen for the MMR2 vaccine given at age 3 years and 4 months, increasing from −9.6% to −13.4%.
The number of children susceptible to measles at age 5 by the end of the study period increased 15-fold, from 1,364 to 20,958, in the least deprived group and 20-fold, from 1,296 to 25,345, in the most deprived group. For rotavirus, a 14-fold increase, from 2,292 to 32,981, was seen in the least deprived group and a 16-fold increase, from 2,815 to 45,201, in the most deprived group.
Regional analysis showed that London had the lowest overall uptake of vaccination, followed by the Midlands and North West. London and the North West region also had greater inequality in vaccine uptake compared with southern regions.
Finally, vaccine uptake was below the recommended 95% WHO threshold throughout the study period for all vaccinations.
These are observational findings, and the researchers acknowledge various imitations including incorrectly recorded uptake rates in some areas, catchup vaccinations, being unable to include children who are not registered at general practices, or capture vaccinations delivered in private settings. Nor can they rule out the possibility that other unmeasured factors may have affected their results.
However, results were similar after further analysis of the data, providing greater confidence in the conclusions.
As such, they conclude: “These findings strongly support the urgent need for effective strengthening of vaccination systems, proportionate to levels of need, in addition to interventions and catchup campaigns in underserved populations.”
END
Study finds widening inequalities in child vaccination rates across England
Vaccine uptake “consistently lower” among children in areas of higher deprivation. Number of children susceptible to measles at age 5 increased 20-fold in most deprived areas
2024-12-12
ELSE PRESS RELEASES FROM THIS DATE:
Investigation raises new concerns over landmark trial for top selling anti-platelet drug
2024-12-12
An investigation published by The BMJ today raises new concerns over the landmark clinical trial (PLATO) that was used to gain worldwide approval for the anti-platelet drug ticagrelor (Brilinta in the US and Brilique in Europe), manufactured by AstraZeneca.
Peter Doshi, senior editor at The BMJ, reveals new details that show problems in data reporting after obtaining primary PLATO trial records and unpublished data through a freedom of information request.
The PLATO trial was published in the New England Journal of Medicine (NEJM) in 2009. Assessing over 18,000 patients in 43 countries, investigators reported that ticagrelor ...
Making chemotherapy for Hodgkin lymphoma kinder to patients
2024-12-12
A simple change to the chemotherapy regimen for people with Hodgkin lymphoma could reduce the long-term health impacts that can result from treatment, according to researchers in Cambridge. The findings could lead to the national guidance on chemotherapy treatment for these patients being revised.
The study, published today in The Lancet Oncology was led by Cambridge University Hospitals NHS Foundation Trust (CUH) and the Wellcome Sanger Institute. It compares the lasting effects of two chemotherapy regimens used to treat Hodgkin lymphoma in younger adults. Hodgkin lymphoma ...
ACS study finds early-onset colorectal cancer cases surge globally
2024-12-12
ATLANTA, December 11, 2024 — A new study led by American Cancer Society (ACS) researchers shows that early-onset colorectal cancer (CRC) incidence rates are rising in 27 of 50 countries/territories worldwide, 20 of which have either exclusive or faster increases for early-onset disease. In 14 countries, including the United States, rates are increasing in young adults while stabilizing in those 50 years and older. The research is published today in the journal The Lancet Oncology.
“The ...
Fluctuating blood pressure tied to problems with thinking skills
2024-12-11
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, DECEMBER 11, 2024
MINNEAPOLIS – Older adults whose blood pressure fluctuates over time may be more likely to have problems with thinking and memory skills, according to a study published in the December 11, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The association was found in Black participants but not in white participants in the study.
The study does not prove that fluctuations in blood pressure cause problems with thinking skills; it only shows an association.
“These results suggest ...
Scientists find promising new target for antidepressants—in the gut
2024-12-11
Researchers have discovered new connections between the gut and brain that hold promise for more targeted treatments for depression and anxiety, and could help prevent digestive issues in children by limiting the transmission of antidepressants during pregnancy.
The study, published in the journal Gastroenterology, shows that increasing serotonin in the gut epithelium—the thin layer of cells lining the small and large intestines—improves symptoms of anxiety and depression in animal studies. The researchers also found ...
Antidepressants may act in gut to reduce depression and anxiety
2024-12-11
NEW YORK, NY (Dec. 11, 2024)--Most of us have experienced the effects of moods and emotions on our gastrointestinal tract, from “butterflies” in the stomach caused by nervousness to a loss of appetite when we’re feeling blue.
A new study in animals suggests that targeting antidepressant medications to cells in the gut could not only be an effective treatment of mood disorders like depression and anxiety but may also cause fewer cognitive, gastrointestinal, and behavioral side effects for patients and their children than current treatments.
“Antidepressants like Prozac and Zoloft that raise serotonin levels are important first-line ...
New PROSPECT-lung trial launches to advance treatment options for operable non-small cell lung cancer
2024-12-11
The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung cancer. The trial, which is the first to open through the newly formed National Cancer Institute (NCI) Clinical Trials Innovation Unit (CTIU), aims to evaluate the role of immunotherapy before and after surgery in patients with non-small cell lung cancer.
The PROSPECT-Lung trial is a large, multicenter trial developed and led by the Alliance for Clinical Trials in Oncology and the SWOG Cancer Research Network and conducted within the NIH-funded NCI National Clinical Trials Network (NCTN), ...
The Welch Foundation honors Rice’s Wang for pioneering contributions to sustainable energy solutions
2024-12-11
The Welch Foundation, one of the nation’s leading private funders of basic chemistry research, has awarded the 2025 Norman Hackerman Award in Chemical Research to Haotian Wang, an associate professor in the Department of Chemical and Biomolecular Engineering at Rice University. Wang is recognized for his groundbreaking contributions to carbon dioxide electrochemistry, which pave the way for sustainable energy solutions.
Wang’s innovative research focuses on harnessing the catalyst-electrolyte ...
Hospital payment caps could save millions of dollars for state employee health plans
2024-12-11
PROVIDENCE, R.I. [Brown University] — State employee health plans could have saved $7.1 billion nationwide by capping hospital payments at 200% of Medicare rates in 2022, a study led by researchers at the Brown University School of Public Health found.
“States are under growing budgetary pressure due to rising health care spending, primarily through increases in hospital and drug prices,” said study author Roslyn Murray, an assistant professor of health services, policy and practice ...
Intraarterial radionuclide therapy safe and effective for advanced meningioma patients
2024-12-11
Reston, VA (December 10, 2024)—Radionuclide therapy delivered directly to an artery is safe and feasible for patients with advanced meningioma, according to new research published in the December issue of The Journal of Nuclear Medicine. In the first long-term study of intraarterial peptide receptor radionuclide therapy (PRRT) in advanced meningioma, patients saw improved radiologic and clinical disease control compared with intravenous PRRT, with no additional toxicity.
Meningiomas are the most common primary neoplasms of the central nervous system and account for more than one-third of all cases. Meningiomas are mostly ...
LAST 30 PRESS RELEASES:
Sleepers made from recycled plastic could make railways even more eco-friendly
Ugh, my stomach: Identifying amino acids that prevent sporulation in food poisoning
Air pollution in India linked to millions of deaths
Study finds widening inequalities in child vaccination rates across England
Investigation raises new concerns over landmark trial for top selling anti-platelet drug
Making chemotherapy for Hodgkin lymphoma kinder to patients
ACS study finds early-onset colorectal cancer cases surge globally
Fluctuating blood pressure tied to problems with thinking skills
Scientists find promising new target for antidepressants—in the gut
Antidepressants may act in gut to reduce depression and anxiety
New PROSPECT-lung trial launches to advance treatment options for operable non-small cell lung cancer
The Welch Foundation honors Rice’s Wang for pioneering contributions to sustainable energy solutions
Hospital payment caps could save millions of dollars for state employee health plans
Intraarterial radionuclide therapy safe and effective for advanced meningioma patients
University of Tennessee and Sheffield sign MOU to facilitate collaborations
Nemours Children’s Health Initiative to start HPV vaccination at age 9 improved completion rates
Nova SBE and New York University Tandon School of Engineering launch transatlantic dual degree program
2025 SPIE-Franz Hillenkamp Postdoctoral Fellowship awarded to Morgan Fogarty
Grants expand roadway safety programs to Native American youth and older drivers
Database documents sex differences in cancer biology, risk, and treatment
University of Virginia's Silvia Blemker recognized by NAI for advancing muscle health through innovation
New study provides a picture of preconception health across three generations in the UK
US veterans report average happiness levels of 5.41 out of 7, with greater happiness most associated with reporting greater purpose in life, lower depressive symptoms, and higher optimism, emotional s
Tattoo or not tattoo: Testing the limits of beauty in body art
New study reveals unique insights into the life and death of Stone Age individuals from modern-day Ukraine
Feeling itchy? Study suggests novel way to treat inflammatory skin conditions
Caltech creates minuscule robots for targeted drug delivery
Noninvasive imaging method can penetrate deeper into living tissue
Researchers discover zip code that allows proteins to hitch a ride around the body
The distinct nerve wiring of human memory
[Press-News.org] Study finds widening inequalities in child vaccination rates across EnglandVaccine uptake “consistently lower” among children in areas of higher deprivation. Number of children susceptible to measles at age 5 increased 20-fold in most deprived areas